相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
Mehdi Mirsaeidi et al.
PULMONARY THERAPY (2023)
Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids
Daniel Wynn et al.
CNS NEUROSCIENCE & THERAPEUTICS (2022)
Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis
Roy Fleischmann et al.
RHEUMATOLOGY AND THERAPY (2022)
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
Roy Fleischmann et al.
RHEUMATOLOGY AND THERAPY (2022)
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
Mehdi Mirsaeidi et al.
PULMONARY THERAPY (2022)
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
Anca D. Askanase et al.
ADVANCES IN THERAPY (2022)
Repository Corticotropin Injection as an Alternative Treatment for Refractory Ocular Mucous Membrane Pemphigoid
Yael Sharon et al.
CORNEA (2022)
Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH1-24 Depot and Methylprednisolone in Healthy Subjects
Nagaraju Poola et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2022)
Results from a Prospective, Open-Label, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye Disease
Melissa Toyos et al.
OPHTHALMOLOGY AND THERAPY (2022)
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Anca D. Askanase et al.
RHEUMATOLOGY AND THERAPY (2021)
Distinct binding and signaling activity of Acthar Gel compared to other melanocortin receptor agonists
Y. Joyce Huang et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2021)
A PHASE 4, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EXPLORATORY STUDY TO ASSESS THE EFFICACY AND SAFETY OF REPOSITORY CORTICOTROPIN INJECTION IN SUBJECTS WITH PULMONARY SARCOIDOSIS (PULSAR): STUDY DESIGN AND BASELINE CHARACTERISTICS
Robert Baughman et al.
CHEST (2021)
Comparison of Steroidogenic Exposure Following the Administration of Repository Corticotropin Injection With a Synthetic ACTH1-24 Depot and Methylprednisolone in Healthy Subjects
Xiaofeng Wang et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
Kyle Hayes et al.
RHEUMATOLOGY AND THERAPY (2021)
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar(R) Gel) for Persistently Active Systemic Lupus Erythematosus
Anca D. Askanase et al.
RHEUMATOLOGY AND THERAPY (2021)
Individual pituitary neuropeptides do not recapitulate the effects of repository corticotropin (Acthar®) on human B cells in vitro
Ann L. Benko et al.
JOURNAL OF NEUROIMMUNOLOGY (2021)
Repository Corticotropin Injection (Acthar(R) Gel) for Refractory Severe Noninfectious Keratitis: Efficacy and Safety from a Phase 4, Multicenter, Open-Label Study
David Wirta et al.
OPHTHALMOLOGY AND THERAPY (2021)
Repository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse
Jeffrey Kaplan et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2021)
Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection
Kyle Hayes et al.
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS (2021)
Treatment of Noninfectious Retinal Vasculitis Using Subcutaneous Repository Corticotropin Injection
Stephen D. Anesi et al.
JOURNAL OF OPHTHALMIC & VISION RESEARCH (2021)
Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model
Chongxu Zhang et al.
SCIENTIFIC REPORTS (2020)
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
Franck F. Rahaghi et al.
EUROPEAN RESPIRATORY REVIEW (2020)
Melanocortin 3 receptor activation with [D-Trp8]-?-MSH suppresses inflammation in apolipoprotein E deficient mice
James J. Kadiri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis
Roy Fleischmann et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Anca D. Askanase et al.
RHEUMATOLOGY AND THERAPY (2020)
A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse
Jeffrey Kaplan et al.
FRONTIERS IN NEUROLOGY (2020)
Activation of Melanocortin Receptors as a Potential Strategy to Reduce Local and Systemic Reactions Induced by Respiratory Viruses
Caterina Lonati et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression
Ladan Zand et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Roy Fleischmann et al.
RHEUMATOLOGY AND THERAPY (2020)
Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis
Nancy Ho-Mahler et al.
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS (2020)
Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States
Winnie W. Nelson et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Repository corticotropin injection reverses critical elements of the TLR9/B cell receptor activation response in human B cells in vitro
Nancy J. Olsen et al.
CLINICAL IMMUNOLOGY (2019)
Adrenocorticotropic Hormone in the Treatment of Focal Segmental Glomerulosclerosis Following Kidney Transplantation
Monica Grafals et al.
TRANSPLANTATION PROCEEDINGS (2019)
Change in visual acuity and retinal structures following Repository Corticotropin Injection (RCI) therapy in patients with acute demyelinating optic neuritis: Improvement in low contrast visual acuity in both affected and contralateral eyes in a single-armed open-label study
Molly Scannell Bryan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records
Ishveen Chopra et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Repository corticotrophin injection exerts direct acute effects on human B cell gene expression distinct from the actions of glucocorticoids
A. L. Benko et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis
Rohit Aggarwal et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Repository corticotropin for Chronic Pulmonary Sarcoidosis
Robert P. Baughman et al.
LUNG (2017)
Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy
James Tumlin et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications
Michael Philbin et al.
ADVANCES IN THERAPY (2017)
Repository corticotropin injection in patients with persistently active SLE requiring corticosteroids: post hoc analysis of results from a two-part, 52-week pilot study
Richard A. Furie et al.
LUPUS SCIENCE & MEDICINE (2017)
A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients
Robert P. Baughman et al.
RESPIRATORY MEDICINE (2016)
Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series
Arvind Madan et al.
BMC NEPHROLOGY (2016)
Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot study
Richard Ririe et al.
LUPUS SCIENCE & MEDICINE (2016)
Adrenocorticotropic hormone analog use for podocytopathies
Edward J. Filippone et al.
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2016)
ACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel Observation
Hasan Arrat et al.
PLOS ONE (2015)
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis
Matthew F. Cusick et al.
AUTOIMMUNITY (2015)
Immunomodulatory effects of HP Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus
D. A. Decker et al.
LUPUS (2014)
Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial
J. J. Fiechtner et al.
LUPUS (2014)
A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (HP ActharA® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy
Michelle A. Hladunewich et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis
Regina Berkovich et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2014)
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis
Barry G. Arnason et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Evidence-based guideline update: Medical treatment of infantile spasms Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
C. Y. Go et al.
NEUROLOGY (2012)
The Melanocortin System in Control of Inflammation
Anna Catania et al.
THESCIENTIFICWORLDJOURNAL (2010)
α-melanocyte-stimulating hormone and related tripeptides:: Biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases
Thomas Brzoska et al.
ENDOCRINE REVIEWS (2008)
分享论文
